A trial looking at lenalidomide after chemotherapy for T cell lymphoma of the skin

This trial was looking at lenalidomide after treatment with chemotherapy for advanced T cell lymphoma of the skin.

T cell lymphomas of the skin (CTCL) are types of non Hodgkin lymphoma. Mycosis fungoides and Sezary syndrome are the most common types of T cell skin lymphomas, although they are still rare.

Doctors usually treat advanced T cell lymphoma of the skin with chemotherapy drugs called gemcitabine or liposomal doxorubicin. You may also have radiotherapy.

Chemotherapy often shrinks or gets rid of the cancer but sadly it can start to grow again. Doctors are looking for treatments to help people in this situation. In this trial they were testing a drug called lenalidomide.

Lenalidomide is a type of biological therapy. It works mainly by helping the body’s immune system target cancer cells.

Doctors wanted to find out

• If having lenalidomide after chemotherapy could prevent or delay the cancer coming back

• More about the side effects